<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04251884</url>
  </required_header>
  <id_info>
    <org_study_id>CE TI 3222</org_study_id>
    <nct_id>NCT04251884</nct_id>
  </id_info>
  <brief_title>Pudendal Nerve Block for Hemorrhoidectomy</brief_title>
  <official_title>Pudendal Nerve Block in Patient Treated for Hemorrhoidectomy Under Spinal Anaesthesia: Prospective Randomized Double-blind Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Francesco Mongelli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale Regionale Bellinzona e Valli</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing Milligan-Morgan hemorrhoidectomy will be randomized to receive or not the
      pudendal nerve block after the spinal anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients included were those undergoing Milligan-Morgan hemorrhoidectomy under spinal
      anaesthesia from January 2018 to December 2019. Exclusion criteria were age &lt; 18 years old,
      pregnancy and allergy to local anaesthetics. Patients meeting inclusion and exclusion
      criteria were randomized to undergo an ultrasound-guided pudendal nerve block. Per-protocol
      all patients received postoperative metronidazole 500 mg for 3 days, laxative, a basis
      analgesia with NSAID and opioids as needed. Postoperative pain on the visual analogue scale
      (VAS) at 6, 12, 24 and 48 hours, opioids needed, complications and length of hospital stay
      were recorded. Patients and ward personnel were not informed about the treatment arm. All
      Patients were further controlled 6 weeks after the intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">January 30, 2020</completion_date>
  <primary_completion_date type="Actual">December 29, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Pain on the Visual Analogue Scale (VAS)</measure>
    <time_frame>at 24 hours after the hemorrhoidectomy</time_frame>
    <description>Visual analogue scale (VAS) ranges from 0 to 10, where 0 is &quot;no pain at all&quot; and 10 is &quot;the strongest pain&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain on the Visual Analogue Scale (VAS)</measure>
    <time_frame>at 6, 12 and 48 hours after the operation</time_frame>
    <description>Visual analogue scale (VAS) ranges from 0 to 10, where 0 is &quot;no pain at all&quot; and 10 is &quot;the strongest pain&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioids Consumption</measure>
    <time_frame>Within 48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lenght of Hospital Stay</measure>
    <time_frame>up to 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications Related to the Pudendal Nerve Block</measure>
    <time_frame>Within 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direct and Indirect Cost Analysis in Out- and In-patients</measure>
    <time_frame>Within the hospital stay</time_frame>
    <description>Ongoing</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Hemorrhoids</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Receiving the pudendal nerve block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Not receiving the pudendal nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local anesthetic (ropivacaine)</intervention_name>
    <description>Patients randomized in the treatment arm will receive a sonography-guided pudendal nerve block</description>
    <arm_group_label>Not receiving the pudendal nerve block</arm_group_label>
    <arm_group_label>Receiving the pudendal nerve block</arm_group_label>
    <other_name>No pudendal nerve block</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Patients affected by haemorrhoids (grade III and IV) and treated with Milligan-Morgan
             hemorrhoidectomy under spinal anaesthesia

          -  Signed informed consent

        Exclusion criteria:

          -  Age &lt; 18 years old

          -  Pregnancy

          -  Allergy to local anaesthetics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ospedale Regionale di Bellinzona e Valli</name>
      <address>
        <city>Bellinzona</city>
        <zip>6500</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>January 30, 2020</study_first_submitted>
  <study_first_submitted_qc>January 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <results_first_submitted>May 2, 2020</results_first_submitted>
  <results_first_submitted_qc>June 4, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 5, 2020</results_first_posted>
  <last_update_submitted>June 4, 2020</last_update_submitted>
  <last_update_submitted_qc>June 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Regionale Bellinzona e Valli</investigator_affiliation>
    <investigator_full_name>Francesco Mongelli</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 8, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/84/NCT04251884/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Receiving the Pudendal Nerve Block</title>
          <description>Ultrasound-guided pudendal nerve block performed with 20 mls Ropivacaine 0.75%.</description>
        </group>
        <group group_id="P2">
          <title>Not Receiving the Pudendal Nerve Block</title>
          <description>No ultrasound-guided pudendal block performed</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Receiving the Pudendal Nerve Block</title>
          <description>Ultrasound-guided pudendal nerve block performed with 20 mls Ropivacaine 0.75%.</description>
        </group>
        <group group_id="B2">
          <title>Not Receiving the Pudendal Nerve Block</title>
          <description>No ultrasound-guided pudendal nerve block performed.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="23"/>
            <count group_id="B2" value="26"/>
            <count group_id="B3" value="49"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.6" spread="18.3"/>
                    <measurement group_id="B2" value="53.3" spread="17.5"/>
                    <measurement group_id="B3" value="52.5" spread="17.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Switzerland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Comorbidities (Cardiologic, Pulmonary, Kidney, Diabetes, Neuropathy)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>• Cardiologic disease</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>• Pulmonary disease</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>• Kidney disease</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>• Diabetes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>• Neuropathy</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Symptoms leading to surgery (itching, pain, bleeding, tenesmus)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Itching</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bleeding</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenesmus</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Postoperative Pain on the Visual Analogue Scale (VAS)</title>
        <description>Visual analogue scale (VAS) ranges from 0 to 10, where 0 is &quot;no pain at all&quot; and 10 is &quot;the strongest pain&quot;</description>
        <time_frame>at 24 hours after the hemorrhoidectomy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Receiving the Pudendal Nerve Block</title>
            <description>Ultrasound-guided pudendal nerve block performed with 20 mls Ropivacaine 0.75%.</description>
          </group>
          <group group_id="O2">
            <title>Not Receiving the Pudendal Nerve Block</title>
            <description>No ultrasound-guided pudendal nerve block performed.</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain on the Visual Analogue Scale (VAS)</title>
          <description>Visual analogue scale (VAS) ranges from 0 to 10, where 0 is &quot;no pain at all&quot; and 10 is &quot;the strongest pain&quot;</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4" spread="1.4"/>
                    <measurement group_id="O2" value="3.1" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Pain on the Visual Analogue Scale (VAS)</title>
        <description>Visual analogue scale (VAS) ranges from 0 to 10, where 0 is &quot;no pain at all&quot; and 10 is &quot;the strongest pain&quot;</description>
        <time_frame>at 6, 12 and 48 hours after the operation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Receiving the Pudendal Nerve Block</title>
            <description>Ultrasound-guided pudendal nerve block performed with 20 mls Ropivacaine 0.75%.</description>
          </group>
          <group group_id="O2">
            <title>Not Receiving the Pudendal Nerve Block</title>
            <description>No ultrasound-guided pudendal nerve block performed.</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain on the Visual Analogue Scale (VAS)</title>
          <description>Visual analogue scale (VAS) ranges from 0 to 10, where 0 is &quot;no pain at all&quot; and 10 is &quot;the strongest pain&quot;</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain on VAS at 6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" spread="2.4"/>
                    <measurement group_id="O2" value="4.6" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain on VAS at 12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4" spread="3.1"/>
                    <measurement group_id="O2" value="4.7" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain on VAS at 48 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="1.6"/>
                    <measurement group_id="O2" value="2.1" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Opioids Consumption</title>
        <time_frame>Within 48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Receiving the Pudendal Nerve Block</title>
            <description>Ultrasound-guided pudendal nerve block with performed 20 mls Ropivacaine 0.75%.</description>
          </group>
          <group group_id="O2">
            <title>Not Receiving the Pudendal Nerve Block</title>
            <description>No ultrasound-guided pudendal nerve block performed.</description>
          </group>
        </group_list>
        <measure>
          <title>Opioids Consumption</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lenght of Hospital Stay</title>
        <time_frame>up to 2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Receiving the Pudendal Nerve Block</title>
            <description>Ultrasound-guided pudendal nerve block performed with 20 mls Ropivacaine 0.75%.</description>
          </group>
          <group group_id="O2">
            <title>Not Receiving the Pudendal Nerve Block</title>
            <description>No ultrasound-guided pudendal nerve block performed.</description>
          </group>
        </group_list>
        <measure>
          <title>Lenght of Hospital Stay</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="1.2"/>
                    <measurement group_id="O2" value="1.8" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Complications Related to the Pudendal Nerve Block</title>
        <time_frame>Within 6 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Receiving the Pudendal Nerve Block</title>
            <description>Ultrasound-guided pudendal nerve block performed with 20 mls Ropivacaine 0.75%.</description>
          </group>
          <group group_id="O2">
            <title>Not Receiving the Pudendal Nerve Block</title>
            <description>No ultrasound-guided pudendal nerve block performed.</description>
          </group>
        </group_list>
        <measure>
          <title>Complications Related to the Pudendal Nerve Block</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="23"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Direct and Indirect Cost Analysis in Out- and In-patients</title>
        <description>Ongoing</description>
        <time_frame>Within the hospital stay</time_frame>
        <posting_date>09/2020</posting_date>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years</time_frame>
      <desc>Any adverse event related to the pudendal nerve block.</desc>
      <group_list>
        <group group_id="E1">
          <title>Receiving the Pudendal Nerve Block</title>
          <description>Ultrasound-guided pudendal nerve block performed with 20 mls Ropivacaine 0.75%.</description>
        </group>
        <group group_id="E2">
          <title>Not Receiving the Pudendal Nerve Block</title>
          <description>No ultrasound-guided pudendal nerve block performed</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The main limitation of the study was represented by the small number of enrolled patients and larger sample are required to confirm our results.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Francesco Mongelli</name_or_title>
      <organization>Ospedale Regionale di Lugano</organization>
      <phone>+41764706297</phone>
      <email>francesco.mongelli@mail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

